A 68-year-old client with type 2 diabetes and stage 3 chroni… | MyMerci
More questions like thisTry ›
Adverse Effects/Contraindications/Interactions

A 68-year-old client with type 2 diabetes and stage 3 chronic kidney disease had simultaneous 2100 orders for insulin degludec and insulin glargine. Neither dose was given until the prescriber and pharmacist clarified the discrepancy and documented one adjusted basal regimen. Review the subsequent glucose, intake, symptoms, and medication-list trend. Select the best interpretation and ongoing plan.

Trend

Choose your responses, then check the answer.

TimeData
2030Glucose 78 mg/dL; 25 percent of dinner eaten; two 2100 basal-insulin orders remain active; client is asymptomatic
2105Neither basal dose administered; prescriber and pharmacist notified; glucose 82 mg/dL; client remains asymptomatic
2130Insulin degludec order discontinued; one adjusted insulin glargine order documented and administered
2300Glucose 92 mg/dL; no sweating, tremor, palpitations, confusion, or change in mental status
0600Glucose 110 mg/dL; client ate 60 percent of breakfast; one basal-insulin order remains active

Q1. How is the client responding after the discrepancy was resolved?

Q2. Which ongoing plan is appropriate?

Explanation
The duplicate order was removed through an authorized clarification, one adjusted basal regimen was administered, and glucose remained above 70 mg/dL without symptoms. Continued monitoring and a clearly reconciled discharge plan are appropriate.
Next question on this topicA client is admitted to the emergency department after ingesting an unknown amount of acet…From this question bank[전통+신유형] NCLEX LEVEL UP 패키지KRW 79,000
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

For study reference only. Always follow current clinical guidelines and your institution’s protocols.